Impact on Pediatric Respiratory Virus Epidemiology Following Nirsevimab Introduction.
BACKGROUND Nirsevimab prevents respiratory syncytial virus (RSV)-associated hospitalizations in infants. However, its impact on the broader epidemiology of acute respiratory infections (ARI) in hospitalized children remains unclear. METHODS We conducted a retrospective study of ARI hospitalizations among children age...